Efficacy of early stereotactic body radiotherapy to the primary lung lesion in patients with NSCLC harboring sensitive EGFR mutations treated with first-line EGFR-TKIs

被引：0
|
作者：
Tao, D. [1 ]
Lei, H. [2 ]
Tan, J. [1 ]
Yang, D. [1 ]
Jiang, Y. [1 ]
Zhou, W. [1 ]
Wang, Y. [1 ]
Wu, Y. [1 ]
机构：
[1] Chongqing Univ, Dept Radiat Oncol, Canc Hosp, Chongqing, Peoples R China
[2] Chongqing Univ, Chongqing Canc Multi Omics Big Data Applicat Engn, Canc Hosp, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2384
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1351P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study
    Wei, H.
    Zhou, X.
    Yang, H.
    Gong, Y-L.
    Wang, J.
    Xu, Y.
    Zhou, L.
    Xue, J.
    Zou, B.
    Zhang, Y.
    Zhu, J.
    Peng, F.
    Huang, M.
    Lu, Y.
    Liu, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S973 - S973
  • [2] Stereotactic body radiotherapy to the lung primary lesion improves the survival of patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: A real-world study.
    Liu, Yongmei
    Wei, Hao
    Zhou, Xiaojuan
    Yang, Hui
    Gong, Youling
    Wang, Jin
    Xu, Yong
    Zhou, Lin
    Xue, Jianxin
    Wen, Zou Bing
    Zhang, Yan
    Zhu, Jiang
    Peng, Feng
    Huang, Meijuan
    Lu, You
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study
    Wei, Hao
    Zhou, Xiaojuan
    Yang, Hui
    Gong, Youling
    Wang, Jin
    Xu, Yong
    Zhou, Lin
    Xue, Jianxin
    Zou, Bingwen
    Zhang, Yan
    Zhu, Jiang
    Peng, Feng
    Huang, Meijuan
    Lu, You
    Liu, Yongmei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2589 - 2598
  • [4] Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study
    Hao Wei
    Xiaojuan Zhou
    Hui Yang
    Youling Gong
    Jin Wang
    Yong Xu
    Lin Zhou
    Jianxin Xue
    Bingwen Zou
    Yan Zhang
    Jiang Zhu
    Feng Peng
    Meijuan Huang
    You Lu
    Yongmei Liu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2589 - 2598
  • [5] Efficacy of first-generation EGFR-TKIs on patients with NSCLC harboring EGFR uncommon mutations: a pooled analysis
    Zhang, Y.
    Tang, S.
    Zhang, J.
    He, Q.
    He, J.
    Liang, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinumbased chemotherapy
    Jinpeng Shi
    Hui Yang
    Tao Jiang
    Xuefei Li
    Chao Zhao
    Limin Zhang
    Sha Zhao
    Xiaozhen Liu
    Yijun Jia
    Yan Wang
    Lei Xi
    Shijia Zhang
    Chunxia Su
    Shengxiang Ren
    Caicun Zhou
    Chinese Journal of Cancer Research, 2017, 29 (06) : 543 - 552
  • [7] Early Stereotactic Body Radiotherapy to the Primary Lung Lesion for Patients with Advanced NSCLC Treated with First-Line Systemic Therapy
    Tao, D.
    Sun, L.
    Wang, L. L.
    Yang, D.
    Jiang, Y.
    Zhou, W.
    Wang, Y.
    Wu, Y. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S128 - S128
  • [8] Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-Line EGFR-TKIs
    Xu, Q.
    Liu, H.
    Xu, Y.
    Zhou, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S93 - S93
  • [9] Local Consolidative Radiation Prolongs Disease Control of Patients with Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-Line EGFR-TKIs
    An, N.
    Wang, H.
    Jing, W.
    Zhu, H.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E494 - E495
  • [10] Stereotactic Body Radiotherapy Plus First-Line EGFR-TKIs for Patients with Advanced EGFR-Mutant Non -Small Cell Lung Cancer: A Meta -Analysis
    Yuan, Z.
    Tao, D.
    Zhou, W.
    Wu, Y. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E85 - E85
12345